Navigation Links
Innovative School of BioPharmacy to Open in Fall 2014
Date:2/27/2012

CLAREMONT, Calif., Feb. 27, 2012 /PRNewswire/ -- The presidents of Chapman University and Keck Graduate Institute (KGI) today announced plans to establish a joint School of BioPharmacy, initially launching at the KGI campus in Claremont, California. The school will focus on preparing graduate pharmacists for professions in biotechnology and the pharmaceutical industry as well as for modern pharmacy practice. The school will open in fall 2014, pending national accreditation. 

"This collaboration is a remarkable opportunity," said James L. Doti, president of Chapman University. "It builds on KGI's innovative professional master's and postdoctoral programs and close biotechnology and pharmaceutical industry ties, and takes advantage of Chapman's strengths in computational sciences and entrepreneurship." 

The new Chapman-KGI School of BioPharmacy will reorient the Doctor of Pharmacy degree toward crucial developments in pharmacogenomics.  The program will reflect rapidly developing changes in the field, including the growth of personalized medicine, the delivery of biomolecules, changes in drug and device development, and progress in clinical trials and team-based operating environments.  The curriculum is planned to equip graduates to become licensed pharmacists with sophisticated knowledge of the applied life sciences for modern health care practice, and experience with therapeutics, therapy management, and regulatory affairs to shape discovery in biotechnology and pharmaceutical companies.  The school's vision reflects the ways in which pharmacists are increasingly asked to shoulder a primary role in matching drugs and therapies to a particular patient or strain of illness, as well as translating their clinical expertise into drug discovery in industry.

"The Chapman-KGI School of BioPharmacy will embrace this change in the profession," said Sheldon Schuster, president and professor of biochemistry at Keck Graduate Institute. "Current advances in genomics and the growing convergence of therapeutics, diagnostics and medical devices are creating new opportunities for pharmacists in the life-sciences industry and modern clinical practice. This new school will help prepare highly qualified individuals to take advantage of those opportunities."

The two universities have begun a national search for an entrepreneurial founding dean with experience in pharmacy education and industry. The first classes for the Chapman-KGI School of BioPharmacy will be held on the KGI campus in Claremont, while Chapman pursues construction of a 120,000-square-foot Science Center in the City of Orange. The new Science Center will house Chapman's portion of the School of BioPharmacy and the university's Schmid College of Science and Technology. KGI is planning a major capital campaign that will expand facilities for ongoing teaching, research programs and the Chapman-KGI School of BioPharmacy, which is expected to grow to a full enrollment of 320 students in the four-year PharmD program.

Keck Graduate Institute of Applied Life Sciences is a member of The Claremont Colleges. Along with other highly regarded graduate programs, KGI offers an innovative professional master's program that integrates pharmacogenomics, pharmaco-economics, bioinformatics and medical informatics, and clinical trial management and regulatory affairs.  

KGI represents The Claremont Colleges' first entry into graduate-level, application-based scientific research and education. It remains the only graduate institute in the country with this sole focus.

Tracing its history to 1861, Chapman University is one of California's oldest and most respected private institutions. The university is known for its commitment to deeply engaged learning, providing its 7,000 students with a remarkable educational environment from the moment they step onto campus. Chapman offers bachelor degrees in 47 majors, and graduate or terminal degrees in law, education, film, business, economics, the humanities and science.


'/>"/>
SOURCE Keck Graduate Institute of Applied Life Sciences; Chapman University
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Innovative Brain Scanning for Alzheimers Screening Unveiled
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Calif. , May 25, 2016  Zymo ... testing for their new reference materials that help ... from sample collection to analyses. The rapid growth ... demand for researchers to have standard methods to ... being generated. Biases inherently exist at every step ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... Blood Pressure products . , High blood pressure affects millions of people ... high blood pressure can lead to heart disease, stroke, kidney disease, and hardening ...
(Date:5/26/2016)... , ... May 26, 2016 , ... HealthPostures, ergonomics designer ... chair , furniture that may support women during pregnancy. Potential benefits of using the ... improved rest and comfort and healthier levels of sitting and standing. , Need for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie is a great option ... and save. For a limited time only (offer expires May 31, 2016) customers can ... one, by using the promo code "Memorial" at checkout. The more Bunion Booties purchased, ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The 12th ... 6pm to 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech ... be led by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract ...
(Date:5/25/2016)... Chicago, IL (PRWEB) , ... May 25, 2016 ... ... HealthScape Advisors,” said Steven Young, a Managing Partner at HealthScape Advisors. “Brad brings ... value-based care within the healthcare delivery system accelerates with the implementation of MACRA, ...
Breaking Medicine News(10 mins):